ReviewHuman vaccines & immunotherapeutics2022
Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives.
Yusuke Nagata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it